TY - JOUR
T1 - Substantial decline of organ preservation fluid contamination following adoption of ischemia-free liver transplantation
T2 - a post-hoc analysis
AU - Lin, Jianwen
AU - Li, Yefu
AU - Fang, Tongdi
AU - Wang, Tielong
AU - Liao, Kang
AU - Zhao, Qiang
AU - Wang, Dongping
AU - Chen, Maogen
AU - Zhu, Xiaofeng
AU - Chen, Yinghua
AU - Chen, Honghui
AU - Guo, Yiwen
AU - Zhan, Liqiang
AU - Zhang, Jiayi
AU - Zhang, Tao
AU - Zeng, Ping
AU - Peng, Yaqin
AU - Yang, Lu
AU - Cai, Changjie
AU - Guo, Zhiyong
AU - He, Xiaoshun
N1 - Publisher Copyright:
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - INTRODUCTION: Preservation fluid (PF) contaminations are common in conventional liver transplantation (CLT) and presumably originate from organ or PF exposures to the external environment in a non-strict sterile manner. Such exposures and PF contamination may be avoided in ischaemia-free liver transplantation (IFLT) because of the strict sterile surgical procedures. In this study, the authors evaluated the impact of IFLT on organ PF contamination. METHODS: A post-hoc analysis using data from the first randomized controlled trial of IFLT was performed to compare the incidence, pathogenic spectrum of PF contamination, and incidence of early recipient infection between IFLT and CLT. Multivariable logistic regression was used to explore risk factors for PF contamination. RESULTS: Of the 68 cases recruited in the trial, 64 were included in this post-hoc analysis. The incidence of culture-positive PF was 9.4% (3/32) in the IFLT group versus 78.1% (25/32) in the CLT group ( P <0.001). Three microorganisms were isolated from PF in the IFLT group, while 43 were isolated in the CLT group. The recipient infection rate within postoperative day 14 was 3.1% (1/32) in the IFLT group vs 15.6% (5/32) in the CLT group, although this difference did not reach statistical significance ( P =0.196). Multivariate analysis revealed that adopting IFLT is an independent protective factor for culture-positive PF. CONCLUSION: PF contamination is substantially decreased in IFLT, and IFLT application is an independent protective factor for PF contamination. Using rigorous sterile measures and effective antibiotic therapy during IFLT may decrease PF contamination.
AB - INTRODUCTION: Preservation fluid (PF) contaminations are common in conventional liver transplantation (CLT) and presumably originate from organ or PF exposures to the external environment in a non-strict sterile manner. Such exposures and PF contamination may be avoided in ischaemia-free liver transplantation (IFLT) because of the strict sterile surgical procedures. In this study, the authors evaluated the impact of IFLT on organ PF contamination. METHODS: A post-hoc analysis using data from the first randomized controlled trial of IFLT was performed to compare the incidence, pathogenic spectrum of PF contamination, and incidence of early recipient infection between IFLT and CLT. Multivariable logistic regression was used to explore risk factors for PF contamination. RESULTS: Of the 68 cases recruited in the trial, 64 were included in this post-hoc analysis. The incidence of culture-positive PF was 9.4% (3/32) in the IFLT group versus 78.1% (25/32) in the CLT group ( P <0.001). Three microorganisms were isolated from PF in the IFLT group, while 43 were isolated in the CLT group. The recipient infection rate within postoperative day 14 was 3.1% (1/32) in the IFLT group vs 15.6% (5/32) in the CLT group, although this difference did not reach statistical significance ( P =0.196). Multivariate analysis revealed that adopting IFLT is an independent protective factor for culture-positive PF. CONCLUSION: PF contamination is substantially decreased in IFLT, and IFLT application is an independent protective factor for PF contamination. Using rigorous sterile measures and effective antibiotic therapy during IFLT may decrease PF contamination.
UR - http://www.scopus.com/inward/record.url?scp=85193310237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85193310237&partnerID=8YFLogxK
U2 - 10.1097/JS9.0000000000001163
DO - 10.1097/JS9.0000000000001163
M3 - Article
C2 - 38329144
AN - SCOPUS:85193310237
SN - 1743-9191
VL - 110
SP - 2855
EP - 2864
JO - International Journal of Surgery
JF - International Journal of Surgery
IS - 5
ER -